RT Book, Section
A1 Papadakis, Maxine A.
A1 McPhee, Stephen J.
A1 Rabow, Michael W.
A1 McQuaid, Kenneth R.
SR Print(0)
ID 1193123595
T1 Gynecologic Disorders Year in Review
T2 Current Medical Diagnosis & Treatment 2023
YR 2023
FD 2023
PB McGraw-Hill Education
PP New York, NY
SN 9781264687343
LK accessmedicine.mhmedical.com/content.aspx?aid=1193123595
RD 2024/04/18
AB The  levonorgestrel  52-mg  intrauterine  device  can  be  inserted  within  5  days  following  a  single  episode  of  unprotected  midcycle  coitus  as  a  postcoital  contraceptive.